Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 256 AL 270

Emerging role of Metformin in Alzheimer's disease: A translational view

Ríos JA, Bórquez JC, Godoy JA, Zolezzi JM, Furrianca MC, Inestrosa NC.

Ageing Res Rev. 2024 Sep;100:102439. doi: 10.1016/j.arr.2024.102439. Epub 2024 Jul 27.

Treating Alzheimer's disease with brain stimulation: From preclinical models to non-invasive stimulation in humans

Lanni I, Chiacchierini G, Papagno C, Santangelo V, Campolongo P.

Neurosci Biobehav Rev. 2024 Oct;165:105831. doi: 10.1016/j.neubiorev.2024.105831. Epub 2024 Jul 27.

How to address the complexity of multi-targeted drug discovery for Alzheimer's disease?

González JF, Sánchez-Montero JM.

Expert Opin Drug Discov. 2024 Oct;19(10):1149-1152. doi: 10.1080/17460441.2024.2385576. Epub 2024 Jul 29.

Aducanumab: A look two years after its approval

Torres A, Camargo L, López N.

Biomedica. 2024 May 31;44(Sp. 1):42-46. doi: 10.7705/biomedica.6967.

Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease

Kamath AP, Nayak PG, John J, Mutalik S, Balaraman AK, Krishnadas N.

Neuropharmacology. 2024 Nov 15;259:110096. doi: 10.1016/j.neuropharm.2024.110096. Epub 2024 Jul 29.

Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease

Abdulhameed N, Babin A, Hansen K, Weaver R, Banks WA, Talbot K, Rhea EM.

Alzheimers Res Ther. 2024 Aug 1;16(1):173. doi: 10.1186/s13195-024-01537-1.

Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis

Wu M, Cheng Y, Zhang R, Han W, Jiang H, Bi C, Zhang Z, Ye M, Lin X, Liu Z.

Biomed Pharmacother. 2024 Sep;178:117228. doi: 10.1016/j.biopha.2024.117228. Epub 2024 Jul 31.

Chromenone: An emerging scaffold in anti-Alzheimer drug discovery

Agarwal U, Verma S, Tonk RK.

Bioorg Med Chem Lett. 2024 Oct 1;111:129912. doi: 10.1016/j.bmcl.2024.129912. Epub 2024 Jul 30.

Therapeutic potential of plant-derived natural compounds in Alzheimer's disease: Targeting microglia-mediated neuroinflammation

Shen Y, Liu F, Zhang M.

Biomed Pharmacother. 2024 Sep;178:117235. doi: 10.1016/j.biopha.2024.117235. Epub 2024 Aug 1.

Frontiers and hotspots evolution in anti-inflammatory studies for Alzheimer's disease

Wu S, Chen N, Wang C.

Behav Brain Res. 2024 Aug 24;472:115178. doi: 10.1016/j.bbr.2024.115178. Epub 2024 Aug 3.

Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease

Ngoc APT, Zahoor A, Kim DG, Yang SH.

J Microbiol Biotechnol. 2024 Sep 28;34(9):1739-1747. doi: 10.4014/jmb.2403.03021. Epub 2024 Jun 21.

Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches

Yassaghi Y, Nazerian Y, Ghasemi M, Nazerian A, Sayehmiri F, Perry G, Gholami Pourbadie H.

J Cell Mol Med. 2024 Aug;28(15):e18554. doi: 10.1111/jcmm.18554.

Overview of a novel osmotin abolishes abnormal metabolic-associated adiponectin mechanism in Alzheimer's disease: Peripheral and CNS insights

Rehman IU, Park JS, Choe K, Park HY, Park TJ, Kim MO.

Ageing Res Rev. 2024 Sep;100:102447. doi: 10.1016/j.arr.2024.102447. Epub 2024 Aug 5.

Quantitative Analysis of Factors of Attrition in a Double-blind rTMS Study for Alzheimer Treatment

Bretecher CA, Verot A, Teschuk JM, Uehara MA, Fitzgerald PB, Koski L, Lithgow BJ, Moussavi Z.

Alzheimer Dis Assoc Disord. 2024 Jul-Sep 01;38(3):288-291. doi: 10.1097/WAD.0000000000000633. Epub 2024 Aug 8.

Emerging paradigms in Alzheimer's therapy

Preethy H A, Rajendran K, Sukumar AJ, Krishnan UM.

Eur J Pharmacol. 2024 Oct 15;981:176872. doi: 10.1016/j.ejphar.2024.176872. Epub 2024 Aug 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias